Showing 61 - 80 results of 26,917 for search '(((( 16 we decrease ) OR ( 50 ((we decrease) OR (nn decrease)) ))) OR ( 100 a decrease ))', query time: 0.50s Refine Results
  1. 61
  2. 62
  3. 63
  4. 64

    Evaluation index results for the JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. …”
  5. 65

    NEMA IEC body phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. …”
  6. 66

    Relationship between contrast, noise, and CNR. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. …”
  7. 67

    JS-10 phantom. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. …”
  8. 68

    The raw data used for the analyses in this study. by Masakazu Tsujimoto (22339504)

    Published 2025
    “…A trade-off between the CV and the SR emerged, depending on the acquisition time and the SI product; optimal results were observed at 50 − 100 s/view and an SI product of 120 − 180. …”
  9. 69

    Data_Sheet_1_Thrombotic Events in COVID-19 Are Associated With a Lower Use of Prophylactic Anticoagulation Before Hospitalization and Followed by Decreases in Platelet Reactivity.d... by Chantal C. Clark (10684632)

    Published 2021
    “…</p><p>Conclusion: We observed an association between the use of preexisting thromboprophylaxis and a decreased risk of TE during COVID-19. …”
  10. 70
  11. 71
  12. 72
  13. 73
  14. 74
  15. 75
  16. 76

    Fig 9 - by Deepu Dowarha (5673440)

    Published 2020
    Subjects:
  17. 77
  18. 78
  19. 79
  20. 80

    Fig 16 - by Deepu Dowarha (5673440)

    Published 2020
    Subjects: